Cargando…
AT‐RvD1 combined with DEX is highly effective in treating TNF‐α‐mediated disruption of the salivary gland epithelium
Sjögren's syndrome (SS) is an autoimmune disorder characterized by chronic inflammation and destruction of salivary and lacrimal glands leading to dry mouth and dry eyes, respectively. Currently, the etiology of SS is unknown and the current therapies have no permanent benefit; therefore, new a...
Autores principales: | Easley, Justin T., Maruyama, Christina L. M., Wang, Ching‐Shuen, Baker, Olga J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5064142/ https://www.ncbi.nlm.nih.gov/pubmed/27694530 http://dx.doi.org/10.14814/phy2.12990 |
Ejemplares similares
-
AT-RvD1 Promotes Resolution of Inflammation in NOD/ShiLtJ mice
por: Wang, Ching-Shuen, et al.
Publicado: (2017) -
Author Correction: AT-RvD1 Promotes Resolution of Inflammation in NOD/ShiLtJ mice
por: Wang, Ching-Shuen, et al.
Publicado: (2018) -
Lung Inflammation Resolution by RvD1 and RvD2 in a Receptor-Dependent Manner
por: Gao, Jin, et al.
Publicado: (2023) -
Effect of RvD1/FPR2 on inflammatory response in chorioamnionitis
por: Li, Anna, et al.
Publicado: (2020) -
Specialized proresolving mediator targets for RvE1 and RvD1 in peripheral blood and mechanisms of resolution
por: Fredman, Gabrielle, et al.
Publicado: (2011)